Rare diseases
Investigational molecules
Locations
Back to France49 clinical trials in Antony, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
FranceStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
FranceStudy of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy
FranceStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
FranceStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
FranceLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
FranceStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
FranceStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
FranceStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
FranceStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceStudy of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG
FranceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Multiple trials are evaluating novel therapeutic approaches for managing these chronic skin conditions.
Several innovative treatments are being tested to improve patient outcomes and quality of life.
Ongoing investigations into treatments for colorectal cancer, multiple myeloma, and bladder cancer. Studies include targeted therapies and novel treatment combinations.
Focus on developing personalized treatment approaches for various cancer types.
Research centered on severe asthma treatment options, particularly focusing on patients with eosinophilic phenotype. Studies are evaluating new biological therapies and treatment comparisons.
Emphasis on developing targeted therapies for specific asthma phenotypes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
